I do wonder why JnJ didn’t parter to distribute the product if they had first dibs? Maybe they think it will cut into their surgical portfolio?
Ann: Successful OrthoATI clinical trial, page-2
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
-0.010(2.74%) |
Mkt cap ! $74.31M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 35.5¢ | $78.83K | 220.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1813 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 2400 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2024 (20 minute delay) ? |
| OCC (ASX) Chart |